Tags : Aerie

PharmaShots Weekly Snapshot (November 18-22, 2019)

1.  Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India Published: Nov 22, 2019 | Tags: Lupin, Launches, Smart Device, Metered-Dose Inhalers, Support, Treatment, Respiratory Diseases, India 2. BioMarin Reports Submission of MAA to EMA for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A Published: Nov 21, 2019 | Tags: BioMarin, […]Read More

Aerie’s Rhokiinsa (netarsudil ophthalmic solution, 0.02%) Receives EC’s Approval for

Shots: The European Commission has granted marketing authorization for Rhokiinsa 0.02% for reducing the elevated intraocular pressure in adult patients with primary open-angle glaucoma or ocular hypertension The EC’s approval demonstrated the potential value of Aerie’s netarsudil franchise at an international level.  The EC has accepted its MAA in Oct’2018 and it has received CHMP’s […]Read More